Medicare’s Access Model Is a Worthy Experiment

Despite the uncertainty around its ultimate results, ACCESS should be given a chance to succeed. After decades of improved treatment of acute conditions, the Medicare population is living longer but with more chronic disease. New technology might improve the management of the symptoms of these conditions. The potential payoff more than justifies the risk of potentially doing no better than the…